Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
Abstract Diabetic macular edema (DME) is a common complication of diabetes that can lead to vision loss, and anti-vascular endothelial growth factor (anti-VEGF) therapy is the standard of care for DME, but the treatment outcomes vary widely among patients. This study collected optical coherence tomo...
Saved in:
| Main Authors: | Xiangjie Leng, Ruijie Shi, Zhaorui Xu, Hai Zhang, Wenxuan Xu, Keyin Zhu, Xuejing Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-82007-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-VEGF for the Management of Diabetic Macular Edema
by: Francisco Rosa Stefanini, et al.
Published: (2014-01-01) -
Anti-VEGF agents in the treatment of diabetic macular edema
by: Vladimir Iosifovich Konenkov, et al.
Published: (2013-12-01) -
Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01) -
Next-Generation Long-Acting Anti-VEGF Therapies for the Treatment of Diabetic Macular Edema
by: Piotr Rzyczniok, et al.
Published: (2025-04-01) -
Ensemble machine learning algorithm for anti-VEGF treatment efficacy prediction in diabetic macular edema
by: Yu Fang, et al.
Published: (2025-07-01)